Updated · AI-assisted evidence analysis
MedPaw™ Hip & Joint Supplement Review 2026: What Does the Evidence Show?
MedPaw joint chews rest on ingredient research, not product or hind-leg evidence — Overhyped
-
"Green-lipped mussel is the best-supported ingredient"
Two placebo-controlled dog trials (45 and 101 dogs) beat placebo on pain or mobility measures. A 2006 trial only separated from placebo at week 8, and a mussel-curcumin blend trial found no difference from placebo. Doses and products differ from MedPaw's undisclosed amount.
Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). → · Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. → · Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. → · The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. → -
"Glucosamine and chondroitin are "the ingredients the research actually supports""
A 2022 review that pooled dog and cat trials found a very marked non-effect of chondroitin-glucosamine on pain and advised against recommending it. Its results are not split out for dogs in the material reviewed. A 2007 dog trial (35 dogs) was positive but had no placebo group and used subjective vet scoring. A 2017 review called the evidence limited and conflicting.
A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. → · Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. → · Glucosamine and chondroitin use in canines for osteoarthritis: A review. → -
"Hyaluronic acid, vitamin E and the rest add joint benefit"
Oral hyaluronic acid in dogs was tested only on joint-fluid markers after surgery. Vitamin E did not improve pain or lameness in a 57-dog trial. A glucosamine, chondroitin and hyaluronic acid blend showed no overall difference from carprofen in 15 working dogs.
Effects of Oral Hyaluronic Acid Administration in Dogs Following Tibial Tuberosity Advancement Surgery for Cranial Cruciate Ligament Injury. → · A blinded, placebo-controlled study on the clinical effects of vitamin E supplementation in dogs with osteoarthritis. → · Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs. → -
"Better hind leg strength, stability and "root cause" of muscle weakness"
The retrieved dog research covers osteoarthritis pain and mobility. None of it tested hind-leg muscle strength or an age-related muscle-energy cause. The page's own explanation of this mechanism is not backed by anything supplied.
Claims vs Evidence
4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Supports joints, hip function and everyday mobility in dogs"
Stretch
Real dog evidence exists for green-lipped mussel (partial), but results are mixed and the products differ. Oral hyaluronic acid has only biomarker data, and vitamin E showed no benefit in one trial. A 2022 review pooling dogs and cats was negative on chondroitin-glucosamine, while a 2007 dog trial without a placebo group was positive. MedPaw prints no per-chew amounts, so no comparison with studied amounts is possible, and no trial of this chew was found.
Source: MedPaw™ Hip & Joint Supplement: manufacturer product page →
Green-lipped mussel (Perna canaliculus) for canine osteoarthritis, Part I
Randomized, double-blind, placebo- and carprofen-controlled trial · ingredient
More dogs improved than on placebo for vet-assessed mobility (P=0.031), owner pain index (P=0.025) and pain VAS (P=0.011). Mussel was less effective than carprofen. No side effects detected.
Limitations: Abstract only. Dose, effect sizes and blinding details unavailable. Single ingredient, not the MedPaw blend.
- Species
- dog
- Participants / condition
- 45 dogs with chronic pain and radiographic osteoarthritis
- Formulation
- Green-lipped mussel preparation; composition not reported in abstract
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 8 weeks, evaluated at 4-week intervals
- Funding / conflicts
- Not reported in abstract
Green lipped mussel plus krill oil extract (EAB-277) vs NSAID vs placebo in dogs with hip osteoarthritis
Block-randomized, double-blind, placebo-controlled, four-arm trial · ingredient
Peak vertical force and orthopedic assessment score improved more than placebo with EAB-277 and meloxicam. The comparison product 4CYTE did not differ from placebo.
Limitations: Mussel product also contains krill oil. Only 6 weeks. Does not test MedPaw's blend or amount.
- Species
- dog
- Participants / condition
- 101 pet dogs with clinical hip osteoarthritis pain
- Formulation
- Green lipped mussel plus krill oil extract (Antinol Rapid, EAB-277); a different product from MedPaw
- Studied amount, not dosing advice
- Not reported in retrieved excerpt
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd.; authors state funder was not involved in design, analysis or writing.
Green-lipped mussel, curcumin and blackcurrant leaf extract supplement in dogs and cats with osteoarthritis
Double-blind, randomized, crossover, placebo-controlled trial (dog results only reported here) · ingredient
Vet-scored COAST improved from baseline but did not differ from placebo. No differences on owner-scored Helsinki Chronic Pain Index or force plate analysis. Several non-responders.
Limitations: Small sample. Blend is not MedPaw. Authors say larger, longer research is needed.
- Species
- dog
- Participants / condition
- 32 client-owned dogs with mild to moderate osteoarthritis (cats also enrolled, excluded here)
- Formulation
- Green-lipped mussel, curcumin and blackcurrant leaf extract blend
- Studied amount, not dosing advice
- Not reported in retrieved excerpt
- Duration
- 16 weeks in dogs
- Funding / conflicts
- Not reported in retrieved excerpt
Oral joint supplement vs carprofen in working dogs with hip osteoarthritis
Randomized controlled trial with positive control, no placebo-only arm · ingredient
No differences in Canine Brief Pain Inventory pain scores between groups. Individual improvements in some dogs, but not in overall results.
Limitations: Very small sample. Abstract only. Cannot separate hyaluronic acid from the other ingredients.
- Species
- dog
- Participants / condition
- 15 working dogs with hip osteoarthritis (10 supplement, 5 carprofen)
- Formulation
- Commercial joint supplement with glucosamine HCl, chondroitin sulphate and hyaluronic acid; not MedPaw
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- Supplement 40 days; follow-up to 5 months
- Funding / conflicts
- Not reported in abstract
Oral hyaluronic acid after tibial tuberosity advancement surgery in dogs
Prospective, randomized, double-blind, placebo-controlled trial · ingredient
Joint-fluid hyaluronic acid rose (p=0.0016) and paraoxonase-1 fell (p=0.011) against the treated group's baseline. No pain, lameness or mobility outcome reported in the abstract.
Limitations: Biomarker study only. Post-surgery population. Does not show dogs moved better.
- Species
- dog
- Participants / condition
- 55 dogs after cranial cruciate ligament surgery
- Formulation
- Oral hyaluronic acid; product details not in retrieved excerpt
- Studied amount, not dosing advice
- Not reported in retrieved excerpt
- Duration
- 10 weeks
- Funding / conflicts
- Bioiberica S.A.U. provided product and funding; one author is employed by Bioiberica.
Vitamin E supplementation in dogs with osteoarthritis
Randomized, blinded, placebo-controlled, double-blind trial · ingredient
No improvement in pain, lameness or quality of life per owners and vets. No reduction in rescue pain relief use.
Limitations: Vitamin E alone, not in a blend. Dose not in retrieved text.
- Species
- dog
- Participants / condition
- 57 client-owned large-breed dogs with naturally occurring osteoarthritis
- Formulation
- Vitamin E supplement; product details not in retrieved excerpt
- Studied amount, not dosing advice
- Not reported in retrieved excerpt
- Duration
- 90 days
- Funding / conflicts
- Not reported in retrieved excerpt
"Helps dogs stand steadier, walk further and get up more easily, including hind leg strength and stability"
No evidence found
No applicable dog research on hind-leg muscle strength or stability for this chew or its ingredient mix was retrieved. Osteoarthritis pain studies are not the same outcome. Owner testimonials on the page are not clinical evidence.
Source: MedPaw™ Hip & Joint Supplement: manufacturer product page →
"Targets the underlying cause of age-related muscle weakness and hind leg decline"
No evidence found
No applicable dog research was retrieved on any listed ingredient acting on muscle energy or the cause of age-related hind leg weakness. The page describes a mechanism and delivery format (dropper, liquid) that does not match the listed chew.
Source: MedPaw™ Hip & Joint Supplement: manufacturer product page →
"Most dogs show noticeable improvement in mobility and comfort within 4–6 weeks of daily use"
Stretch
Ingredient trials show improvement is slow and uneven. In the 2006 mussel trial both groups improved by day 28 with no group difference, and treatment only separated from placebo at day 56. The page also gives a different timeline (2–4 weeks) elsewhere. No trial of this chew supports "most dogs".
Source: MedPaw™ Hip & Joint Supplement: manufacturer product page →
Green-lipped mussel extract in dogs with presumptive degenerative joint disease
Double-blind, placebo-controlled trial with open-label extension · ingredient
Both groups improved by day 28 with no group difference. At day 56 more mussel dogs improved (p=0.018); musculoskeletal scores were marginal (p=0.053). Group differences gone by day 112.
Limitations: Abstract only. Subjective owner and single-vet scoring. Strong placebo response.
- Species
- dog
- Participants / condition
- 81 dogs with presumptive mild-to-moderate degenerative joint disease
- Formulation
- Green-lipped mussel extract; composition not reported in abstract
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 56 days blinded, plus 56 days open-label
- Funding / conflicts
- Not reported in abstract
Green lipped mussel added to a complete dry diet in dogs with arthritis
Double-blind, randomized, controlled trial · ingredient
Total arthritis score improved vs control (P<.05), including pain and swelling. Joint crepitus and range of movement did not differ.
Limitations: Small sample. Abstract only. Diet-based delivery differs from a chew.
- Species
- dog
- Participants / condition
- 31 mixed-breed dogs with varying degrees of arthritis
- Formulation
- 0.3% green-lipped mussel powder added to a dry diet
- Studied amount, not dosing advice
- 0.3% of diet as study description
- Duration
- 6 weeks
- Funding / conflicts
- Not reported in abstract
Glucosamine/chondroitin sulfate vs carprofen in dogs with osteoarthritis
Randomized, double-blind, positive-controlled multicentre trial; no placebo group · ingredient
Significant improvement in pain, weight-bearing and severity by day 70 (P<0.001). Onset slower than carprofen.
Limitations: No placebo arm. Subjective vet scoring. Abstract only. Contrasts with the 2022 pooled dog-cat meta-analysis.
- Species
- dog
- Participants / condition
- 35 dogs with osteoarthritis of hips or elbows
- Formulation
- Glucosamine hydrochloride plus chondroitin sulfate
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 70 days treatment, reassessed day 98
- Funding / conflicts
- Not reported in abstract
Boswellia resin in canine inflammatory joint and spinal disease
Open-label, uncontrolled multicentre trial, before-and-after · ingredient
Overall efficacy reported in 71% of 24 eligible dogs after 2 weeks. Significant reduction in lameness, pain and stiff gait by 6 weeks. Brief diarrhea and flatulence in 5 dogs.
Limitations: No control group. Product-specific extract. MedPaw's Boswellia amount is not disclosed.
- Species
- dog
- Participants / condition
- 29 dogs with chronic joint and spinal disease; osteoarthritis confirmed radiologically in 25
- Formulation
- Boswellia serrata resin extract (BSB108), given with food
- Studied amount, not dosing advice
- 400 mg/10 kg body weight once daily as study description
- Duration
- 6 weeks
- Funding / conflicts
- Not reported in abstract
Signals
- "Vet-Approved" and "Vet recommended" appear with no named vet, panel or review process on the page.
- The 92%, 91% and 95% owner figures and "most advanced" or "unmatched quality" wording have no named study, sample or method.
- The page claims "meaningful doses" of glucosamine, chondroitin and omega-3s, but no per-chew amounts are printed.
- The page contradicts itself: a soft chew vs "dropper" and "liquid delivery", a 60-day vs 14-day guarantee, and 2–4 vs 4–6 weeks to results.
- The full ingredient composition list is printed on the product page.
- A weight-based feeding guide is shown, with chews per day by dog weight.
Evidence checks
Species and formulation relevance
All dog study rows are trials of single ingredients or different blends, so each is ingredient-level evidence. The 2022 review (pmid36142319) pools dogs and cats and is cited in prose only, not as a dog evidence row. No exact-product trial of MedPaw was found in this search. Amounts in the chew are not disclosed, so no comparison with studied amounts was possible.
Label transparency
The ingredient list is printed in full, but no per-chew amounts are. The page gives mismatched details (chew vs dropper/liquid, 60- vs 14-day guarantee, Large 18–45 kg vs feeding guide bands). Owner testimonials and survey percentages have no named source.
Independent quality testing
No third-party test, batch analysis or quality seal for this product was shown in the reviewed material. One retrieved study (pmid31370899) found wide variation between measured and labelled boswellic acid in other dog supplements, which is why verification matters. It is not a test of this product.
Strength of the dog research
Most dog sources are abstracts only, with small samples, subjective scoring and strong placebo responses. Several trials are industry-funded. The 2022 meta-analysis (pmid36142319) pools dogs and cats, did not separate out dog results in the excerpt reviewed, and was negative on chondroitin-glucosamine, while single dog trials were positive for mussel.
Sources (13)
- 1. MedPaw™ Hip & Joint Supplement: manufacturer product page →
Manufacturer · Accessed 2026-11-11
- 2. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. →
Study · Accessed 2026-11-11
- 3. Glucosamine and chondroitin use in canines for osteoarthritis: A review. →
Research review · Accessed 2026-11-11
- 4. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. →
Research review · Accessed 2026-11-11
- 5. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. →
Study · Accessed 2026-11-11
- 6. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. →
Study · Accessed 2026-11-11
- 7. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). →
Study · Accessed 2026-11-11
- 8. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. →
Study · Accessed 2026-11-11
- 9. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. →
Study · Accessed 2026-11-11
- 10. Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs. →
Study · Accessed 2026-11-11
- 11. Effects of Oral Hyaluronic Acid Administration in Dogs Following Tibial Tuberosity Advancement Surgery for Cranial Cruciate Ligament Injury. →
Study · Accessed 2026-11-11
- 12. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. →
Study · Accessed 2026-11-04
- 13. A blinded, placebo-controlled study on the clinical effects of vitamin E supplementation in dogs with osteoarthritis. →
Study · Accessed 2026-11-03
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-11. These checks are not veterinary review.
Research scope and outstanding checks
Searched Europe PMC-style queries on nutraceutical osteoarthritis systematic reviews, the MedPaw name, and individual ingredients (MSM, Boswellia serrata, flax seed, vitamin E) with dog terms. This is not an exhaustive search. No MedPaw trial and no applicable dog study for MSM or flax seed osteoarthritis was found in the supplied sources. Many sources were abstract-only, so methods, doses and conflicts are often unavailable. Human, cat and rodent evidence was excluded. The pooled dog-cat 2022 review is described as pooled evidence and is not used as a dog-only evidence row. Turmeric, collagen, mesotherapy and survey studies were not used as ingredient evidence for this formula.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (MedPaw AND Hip AND Joint) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (MedPaw AND Hip AND Joint) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Methyl AND TITLE_ABS:sulphonyl AND TITLE_ABS:methane AND TITLE_ABS:MSM AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Methyl AND TITLE_ABS:sulphonyl AND TITLE_ABS:methane AND TITLE_ABS:MSM AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Boswellia AND TITLE_ABS:serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Boswellia AND TITLE_ABS:serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Flax AND TITLE_ABS:Seed AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Flax AND TITLE_ABS:Seed AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Vitamin AND TITLE_ABS:E AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Vitamin AND TITLE_ABS:E AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- Per-chew amounts of glucosamine, chondroitin, green-lipped mussel, MSM, Boswellia, hyaluronic acid and flax seed
- Any trial of the MedPaw chew itself
- Source, sample and method for the 92%, 91%, 95% and 96% figures
- Identity and credentials behind the "vet-approved" claim
- Third-party testing or a named quality seal for this product
- Applicable dog studies for MSM and flax seed in the supplied sources
- Dog-only results for chondroitin-glucosamine from the 2022 pooled dog-cat review